Daniel Schultz, MD, acting director of the FDA’s Center for Devices and Radiological Health (CDRH) since April, last month had the “acting” term removed from his title by acting FDA Commissioner Lester Crawford. In announcing the appointment of Schultz to head CDRH, the agency’s medical device unit, Crawford said he “brings to our medical device program the ideal combination of skills, experience and temperament to ensure that FDA’s medical device program is second to none.